167 filings
Page 5 of 9
8-K
yjtcq6kimp3ac0ionx0
10 Jan 19
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
5:04pm
8-K
pcn4wc
9 Jan 19
Cancer Genetics Strengthens Management Team with Appointmentof William Finger as Executive Vice President, Precision Medicineand Pharma Services
9:12am
8-K
mn7zfekhqwy lh9ew0
7 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
a1wfw2t002cvk
21 Dec 18
Other Events
4:05pm
8-K
uf19ncwolxrkbnxgk
17 Dec 18
Cancer Genetics Terminates Proposed Merger with NovellusDx
8:31am
8-K/A
9o1pn0az
21 Nov 18
Departure of Directors or Certain Officers
4:10pm
8-K
s7nzra3ol0s3f9sy3jgi
19 Nov 18
Provides Strategic Business Updates
4:56pm
8-K
743tx3
16 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
qkm0hxy14kbb u8b
14 Nov 18
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
4:44pm
8-K
7a8bgm82
16 Oct 18
Cancer Genetics Issues Letter to Shareholders
4:05pm
8-K
vmkdemue aw6
9 Oct 18
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
8:47am
8-K
do6yas51iim2w8r
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
3bf3gqjwnwoq
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
seasm
14 Aug 18
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
7:35am
8-K
47std0ke3kp
13 Aug 18
Departure of Directors or Certain Officers
4:05pm
8-K
5uxno59zk rg
9 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
yyden2occv5bjwx
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm
8-K
fztk71 s2hs
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
fmh3bzf dxi2h
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
x7kft aazm9vu
13 Jun 18
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12:00am